Nuwellis completes acquisition of Rendiatech

Nuwellis (NUWE) completed its acquisition of Rendiatech, an Israeli-based developer of automated kidney function monitoring technology designed to support clinical decision-making in critically ill patients. Rendiatech has no commercial operations and was formed to acquire certain assets of RenalSense following its bankruptcy proceedings; the company purchased Rendiatech primarily to gain access to such assets. Rendiatech’s technology enables automated, continuous renal monitoring with real-time data capture, replacing manual collection and intermittent readings.